Award recordCONTRACT

OTSUKA AMERICA PHARMACEUTICAL INC

PIID 36C24622F0094· VHA· 246-NETWORK CONTRACTING OFFICE 6 (36C246)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $136,002 net obligations· UEI QKABLBMA8FT9· MD

Description

JYNARQUE TABLETS 60MG/30MG

First action · last action
2021-12-30 · 2022-05-27
Transactions
3
First transaction's obligation
$123,827
Base + all options value (sum of deltas)
$136,002
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0099
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$137,115$0Base award · 2021-12-30 · this action $123,827 · running total $123,827Modification P00001 · 2022-01-05 · this action $13,287 · running total $137,115Modification P00002 · 2022-05-27 · this action -$1,113 · running total $136,002
  • Base2021-12-30+$123,827= $123,827
  • Mod P000012022-01-05+$13,287= $137,115
  • Mod P000022022-05-27-$1,113= $136,002
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-12-30+$123,827$123,827JYNARQUE TABLETS 60MG/30MG
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-01-05+$13,287$137,115JYNARQUE TABLETS 60MG/30MG
Mod P00002· CLOSE OUT2022-05-27−$1,113$136,002JYNARQUE TABLETS 60MG/30MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QKABLBMA8FT9)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0783245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$20,378FY2026
36C24525N0988245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,243FY2025
36C24525N0987245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0901245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0789245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025
36C24525N0683245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$13,168FY2025

Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24626N1034PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$72,362FY2026
36C24626A0027PROGENICS PHARMACEUTICALS INC246-NETWORK CONTRACTING OFFICE 6 (36C246)$0FY2026
36C24626N0890PROGENICS PHARMACEUTICALS INC246-NETWORK CONTRACTING OFFICE 6 (36C246)$1,212,530FY2026
36C24626N0782PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$72,563FY2026
36C24626N0690PARTNER THERAPEUTICS, INC.246-NETWORK CONTRACTING OFFICE 6 (36C246)$54,422FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24622F0094_3600_36F79720D0099_3600 · retrieved 2026-09-26.